... Passos-Bueno MR, Vainzof M, Marie SK, Zatz M: Half the dys-trophin gene apparently enough for a mild clinical course:confirmation of its potential use for gene therapy. Hum MolGenet 1994, 3:919-922.5. ... cells: 1 fold DMD/DMBmuscle cells), co-cultures were performed with 50% of themedium used for CD34+ stem cells and 50% of themedium used for myoblasts. They were established into25 cm2 plastic ... positive results of the in vivo injections, theinteraction of these cells with human dystrophic musclecells is still unknown. Here we have investigated, for thefirst time, the potential of umbilical...